Antibiotics
Published by Multidisciplinary Digital Publishing Institute (MDPI)
eISSN : 2079-6382
Abbreviation : Antibiotics
Aims & Scope
Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics.
Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology.
Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.
Therefore, there is no restriction on the length of papers.
Unique features of this journal: manuscripts regarding original research and ideas will be particularly welcomed.
Antibiotics also accepts reviews, clinical studies and case reports, communications, and short notes. computed data or files regarding the full details of experimental procedures can be deposited as supplementary material.
Scope: advances in research on new and current antibiotics and related bioactive medicinal agents, antibiotic administration, drug-drug interactions and pharmacodynamics, biochemical and genetics studies on microorganisms for improved antibiotics, uses of antibiotics, including on animals and in agriculture, clinical trials, new methods for assaying and evaluating antibiotics, production and characterization of antibiotics, classes of antibiotics, antibiotic resistance and misuse, natural antibiotics, epidemiology of antimicrobial use, antimicrobial stewardship, qualitative and quantitative research exploring the determinants of antimicrobial use and resistance, prescribing sciences.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 4.6 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.114 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
Journal Rank
Year | Value |
---|---|
2024 | 4041 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 26151 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,900.00 CHF. Learn more.
Explore journals without APCs for alternative publishing options.